Healio

First-in-human trial evaluates dosing of metallo-beta-lactamase inhibitor

Please provide your email address to receive an email when new articles are posted on . A metallo-beta-lactam inhibitor could help fight resistance to beta-lactam antibiotics. MK-3402 was found to be ...
Business Wire

Venatorx Pharmaceuticals Announces FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI ...

MALVERN, Pa.--(BUSINESS WIRE)--Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant ...
Healio

Beta-lactam de-escalation may be an important tool in AMR prevention

Please provide your email address to receive an email when new articles are posted on . De-escalation of beta-lactam antibiotics was associated with a decreased risk of new resistance among patients ...
Medscape

Non-Beta-Lactam Prophylaxis Tied to Surgical Infection Risk

Surgical antimicrobial prophylaxis using non-beta‑lactams administered before major surgery was independently associated with a significantly higher risk for surgical site infection than conventional ...